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including 64 (0.62%) anomalous origin of coronary artery, 180 (1.72%)
anomalies of intrinsic coronary arterial anatomy, 24 (0.23%) coronary
artery ﬁstula, and 4 (0.04%) number anomalies of coronary artery.
Among anomalous origin of coronary artery, RCA originating from the
left sinus of Valsalva (n¼27, 0.26%), high take-off of the RCA (n¼14,
0.13%) and LCX originating from the right sV (n¼12, 0.11%) were the
top three types of anomalies. Among anomalies of intrinsic coronary
arterial anatomy, the frequencies of hypoplasia is 1.24%, aneurysms
0.41%, and coronary atresia 0.01%. No gender differences were pre-
sented in the frequencies of most CAAs, except that LCX originating
from the right sinus of Valsalva occurred more frequently in males
than females (0.11% vs. 0.01%, p¼0.027). Furthermore, clinical rele-
vance based classiﬁcations of CAAs were similar in the males and
females.
CONCLUSIONS 320-slice computed tomography can serve as a non-
invasive technique for clinical detection of CAAs.
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Mesenchymal Stem Cells Engineered with Integrin-Linked Kinase Improves
Cardiac Function Paralleled with Enhanced Homing Capacity Following
Intracoronary Transplantation in Porcine Myocardial Infarction
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OBJECTIVES Mesenchymal stem cell (MSCs)-based therapy is under
investigation for treating acute myocardial infarction (MI) but is
limited due to poor engraftment and limited regenerative potential.
Integrin-linked kinase (ILK) overexpression enhances progenitor cells
homing, promotes cardiomyogenesis, reverses myocardial remodeling
and improves cardiac function. We sought to engineer MSCs with ILK
and evaluate their therapeutic potential on acute MI in a large-animal
model supposing a synergistic effect of MSC and ILK could be
achieved.
METHODS Minipigs underwent a 90-minute balloon occlusion of the
left anterior descending coronary artery followed by reperfusion. ILK-
engineered MSCs were intracoronary transplanted 71 days after oc-
clusion, as were vector-engineered MSCs and vehicle controls. Both
cells were GFP- and iron-labeled before transplantation and were
monitored in vivo by cardiac magnetic resonance imaging (CMR). CMR
was also used to measure global and regional left ventricular (LV)
function, scar size and perfusion.
RESULTS No impairment occurred in biological properties of MSCs
following iron labeling at 50mg/ml. Signiﬁcantly enhanced homing
capacity of MSCs following ILK modiﬁcation was revealed by MRI in
vivo and conﬁrmed by histological staining. Intracoronary trans-
plantation of ILK-engineered MSCs improves global LVEF by 7.8%
compared with baseline (P ¼ 0.03), and 11.7% when compared with
vehicle (P ¼ 0.02) 15 days post-implantation. Regional LV contractile
function was also recovered (P < 0.001), accompanied by substantially
reduced scar size (P < 0.001), myocardial remodeling (P < 0.05), cell
apoptosis (P < 0.001), and increased regional perfusion (P < 0.001)
and cardiac cell proliferation (P < 0.001) in ILK-MSC treated minipigs
versus vehicle controls. Vector-engineered MSC did not produce sig-
niﬁcant improvement in global LVEF or reduction in cardiac remod-
eling compared with baseline or vehicle controls, and generated less
extent of all other favorable effects compared with ILK-modiﬁed
MSCs.
CONCLUSIONS ILK-engineered allogeneic MSCs enhance regional
and global LV function, reverse the remodeling process and restore
regional perfusion with an improved homing capacity following
intracoronary transplantation. Engineering MSCs with ILK has great
potential implication for cell therapy in post-MI patients.
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Impact of body mass index on mortality in patients with diabetes:
Meta-analysis of 20 studies including 250,016 patients
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OBJECTIVES The inﬂuence of body weight on mortality among pa-
tients with diabetes remains controversial. Therefore, we performed a
meta-analysis of pertinent studies.METHODS We searched OVID/MEDLINE, EMBASE and Cochrane da-
tabases for all reported studies, published before Dec 2014, which
investigated the relationship between body mass index (BMI) and
mortality in patients with diabetes. Summary estimates of hazard
ratios (HRs) were obtained with a random effects model. Univariate
meta-regressions were performed.
RESULTS Twenty studies including 250,016 patients with diabetes
were identiﬁed. The meta-analysis demonstrated a signiﬁcantly
reduced risk of all-cause mortality in overweight patients (HR 0.82,
95% CI 0.74 to 0.91, P<0.0001, and I2 ¼91.6%) as compared to normal
weight patients. The survival beneﬁts of obesity was only observed in
the elderly patients (HR 0.69, 95% CI 0.63 to 0.75, P<0.0001, and
I2 ¼50.4%), but not in the younger patients (HR 1.01, 95%CI 0.84 to
1.20, P¼0.96, I2 ¼80.1%). Moreover, meta-regression analysis indi-
cated that the beneﬁcial prognostic impacts on overweight (Coef-
ﬁcient¼0.030; p¼0.041) and obesity (Coefﬁcient ¼0.032; p¼0.010)
were attenuated with clinical follow-up duration.
CONCLUSIONS Our meta-analysis indicated a signiﬁcantly lower risk
of mortality in overweight patients with diabetes compared to normal
weight patients. However, the survival beneﬁts of obesity were only
observed among the elderly patients.
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OBJECTIVES Coronary artery disease (CAD) is a chronic inﬂammatory
disease involving the complex interplay between multiple genetic and
environmental factors. As a central regulator of inﬂammation, NF-kB
plays an important role in the development and progression of in-
ﬂammatory diseases. The aim of this study was to investigate whether
promoter polymorphisms in NFKB1 and NFKBIA gene contribute to
CAD in a Chinese Han population.
METHODS This is a case-control study. NFKB1 promoter poly-
morphism (-94ins/del ATTG) and NFKBIA promoter polymorphisms
(-881A/G, -826C/T, and -297C/T) were genotyped using TaqMan SNP
genotyping assays in 1140 Han CAD cases and 1156 Han CAD-negative
controls, and then NFKBIA haplotype blocks were reconstructed ac-
cording to our genotyping data.
RESULTS No statistical signiﬁcance was observed for the distribution
frequency of the NFKBIA -881 A/G, -826 C/T, or -219 C/T allele, ge-
notype and haplotype polymorphisms between CAD cases and con-
trols. None of the studied NFKBIA SNPs were associated with CAD.
There was signiﬁcant difference in the distribution of the genotypes
(P ¼ 0.001) and alleles (P¼0.001) of NFKB1-94ins/del polymorphism in
CAD cases and controls. The homozygous variant genotype of NFKB1-
94ins/del ATTG was consistently associated with increased risk of
CAD among all participants after adjustment for covariates (OR¼1.505,
95% CI 1.190 to 1.903, P ¼ 0.001).
CONCLUSIONS In our study, we did not detect any relationship be-
tween NFKBIA promoter polymorphisms and CAD. However, the -94
ins/del polymorphism in NFKB1 promoter affects the susceptibility for
CAD in Chinese Han population, providing a new insight into the
genetic basis of CAD in Chinese Han population.
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OBJECTIVES Thymus involution can contribute to immune distur-
bance. This study aimed to explore whether recent thymic export
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tery disease (CAD).
METHODS Content of signal-joint T cells receptor excision circles (sj-
TREC) in T lymphocytes, a molecular marker of RTEs, were assessed
among CAD patients and age-matched controls. Monochrome multi-
plex quantitative PCR method was used to assess samples’ telomere
length, a known indicator of increased cell division. Neutrophils to
lymphocytes ratio (NLR) was calculated to reﬂect the severity of in-
ﬂammatory status. Patients were grouped according to Gensini score
(GS) tertile (low GS<18; intermediate GS 18-41, high GS >41). Predic-
tive value of sj-TREC for disease status was evaluated according to
ordinary logistic regression models.
RESULTS Average copy numbers of sj-TREC per 106 T lymphocytes
among patients with non-ST-elevation acute coronary syndrome
(NSTACS), stable angina (SA) and controls were 877494, 1222539
and 1803 817, respectively (P<0.001). No signiﬁcant difference of
telomere length was found among three groups. NLR was signiﬁ-
cantly higher in NSTACS patients (3.92.9) than SA patients (2.41.1,
P<0.01) and controls (2.10.9, P<0.001). Negative correlation be-
tween sj-TREC and NLR was uncovered (R¼-0.3312, P<0.0001). Sj-
TREC level between SA and NSTACS patients was signiﬁcantly
different in the 50-64 years cohort (P<0.001), but not in the 65-80
cohort. Sj-TREC level showed a negative correlation with age among
healthy controls (R¼-0.5052, p¼0.0005) and SA patients (R¼-0.5158,
p¼0.005), but not NSTACS patients (R¼-0.1415, P¼0.0991). Content of
sj-TREC in high GS group (GS>41) was most signiﬁcantly reduced than
low GS group (GS <18) (P<0.001). Ordinal logistic regression analysis
revealed that higher sj-TREC level was independently associated with
absence of CAD (OR¼0.35, P<0.001) and low Gensini score (OR¼0.21,
P<0.001).
CONCLUSIONS Signiﬁcantly reduced sj-TREC level in SA and NSTACS
patients mainly resulted from decreased thymic output rather than
increased T cell proliferation. Patients with more sever inﬂammatory
status had lower RTEs of T cells. Content of sj-TREC could be inﬂu-
enced both by age and CAD status. Sj-TREC level from elderly patients
was too low to notice a signiﬁcant difference between SA and NSTACS
patients. Unlike the case with controls and SA patients, content of sj-
TREC was so low in NSTACS patients that it appeared no longer
signiﬁcantly related to age among them. Patients with higher GS had
more complicated plaques and might have poorer thymic function.
Ordinal logistic regression analysis demonstrated that higher sj-TREC
level was an independent protective factor to CAD status. In conclu-
sion, accelerated thymic involution may be partly responsible for the
development of CAD via the alteration of equilibrium of peripheral T
cells compartments and interruption of maintained immune toler-
ance.
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Allocrytopine attenuates cardiac transmural dispersion of repolarization
and protects ischemia reperfusion induced arrhythmias in rabbits
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OBJECTIVES Ischemia reperfusion injury is known to impaire cardiac
function in ischemic heart diseases (IHD). Allocryptopine is a botan-
ical alkaloid extracted from Corydalis decumbens (Thunb) Pers Papa-
veraceae. Lately great attention has been paid to its anti-arrhythmic
effects. We hypothesized that allocryptopine can provide protection
against ischemia reperfusion (I/R) injury though reducing transmural
heterogeneity of repolarization in rabbit heart.
METHODS The LADs ligation were conducted to block the blood ﬂow
and reperfuse the myocardium of 48 allocryptopine pretreatment
rabbits. Body-surface electrocardiograms and monophasic action po-
tential (MAP) were recorded before and after acute ischemia and
reperfusion. Transmembrane action potential durations from epicar-
dium, midcardium and endocardium were simultaneously recorded
together with the occurrence of triggered activities and malignant
ventricular arrhythmias.
RESULTS The acute ischemia and subsequent reperfusion shortened
the monophasic actin potential duration (MAPD) of epicardium,
midcardium and endocardium and increased transmural dispersion of
repolarization (TDR) in operation alone group. Treatment of alloc-
ryptopine preferentially prolonged the MAPD50 and MAPD90 of
epicardium and endocardium rather than midcardium, thereby reducethe TDR of ischemia/reperfusion myocardium from 52.38.7 ms/
69.08.0 ms to 30.55.0 ms/ 33.07.0 ms (P ¼0.002). Nine rabbits
were observed early-afterdepolarizations (EADs) and thirteen rabbits
were experienced frequent ventricular tachyarrhythmias during LADs
ligation. Allocryptopine intervention successfully suppressed the I/R-
induced arrhythmias by 35.4% (P ¼0.018).
CONCLUSIONS Allocryptopine maintains the electrophysiological
heterogeneity of repolarization among myocardial layers and effec-
tively prevents I/R induced arrhythmias.
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OBJECTIVES To observe the efﬁcacy and safety of recombinant hu-
man brain natriuretic peptide (rh-BNP) combined with levosimendan
in treating patients with acute myocardial infarction complicated with
heart failure.
METHODS Hospitalized patients who suffered from anterior wall AMI
with heart failure ( KillipIIwIII ) within 12 to 24 hours from the onset
of chest pain were randomized into two groups (n¼30, respectively):
control group (receiving dobutamine and/or cedilanid on the basis of
essential therapy) and experimental group (receiving rh-BNP com-
bined with levosimendan on the basis of essential therapy). The he-
modynamics, clinical parameters of test and adverse events were
observed before and after treatment.
RESULTS In experimental group, compared with those before treat-
ment, there were statistical differences in respiratory rate (RR), heart
rate (HR), systolic blood pressure (SBP), arterial blood gas oxygen
saturation (SaO2), cardiac index (CI), extravascular lung water index
(EVLWI) at 2h and the following time points after treatment(all
P <0.05). In control group, compared with those before treatment,
there were statistical differences in RR, HR, SaO2, CI, EVLWI at 6h
after treatment and in the next time points (all P <0.05). RR, HR, SBP,
SaO2, CI, EVLWI at 2h and 6h after treatment had statistical differ-
ences between two groups, and the differences in RR, HR, CI, EVLWI
persisted for 72 hours after medicine administration. There was a
statistically signiﬁcant difference between two groups in urine vol-
ume, plasma NT-proBNP concentration, left ventricular ejection
fraction (LVEF) and length of stay in CCU (all P <0.05). For adverse
events monitoring, there was no signiﬁcant change between two
groups in hepatic parameters, electrolyte level and coagulation
function before and after treatment.
CONCLUSIONS rh-BNP combined with Levosimendon is superior to
the conventional drugs in improving hemodynamics, increasing urine
volume, decreasing the plasma NT-proBNP concentration, improving
clinical symptoms, increasing LVEF, and reducing the length of stay in
CCU in patients with acute myocardial infarction complicated with
heart failure, which has better tolerance and safety.GW26-e0268
Incidence and Predictors Of Prolonged Dual Antiplatelet Therapy Among
Patients After Percutaneous Coronary Intervention
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OBJECTIVES The optimal duration of dual antiplatelet therapy
(DAPT) after percutaneous coronary intervention (PCI) remains
controversial. The present study sought to elucidate the frequency
and predictors of DAPT beyond 12 months after stent deployment in
Chinese population.
METHODS We examined the incidence of extended DAPT at 12
months follow-up among patients after successful PCI enrolled in a
28-site Chinese registry. Predictors of prolonged DAPT beyond 12
months were evaluated using multivariable cox proportional hazards
model.
RESULTS Among 2,130 patients, DAPT was continued in 46% (n¼983)
beyond 12 months after stent implantation. There was a signiﬁcant
heterogeneity of DAPT duration among centers. Compared to those
